Emory University Fragile X Group Receives NIH Program Grant

January 26, 1998

Researchers from seven interrelated and collaborative projects all focusing on fragile X syndrome, the most frequent cause of inherited mental retardation in humans, have received a program project grant from the National Institutes of Health (NIH) totaling approximately $3.7 million. The research group, assembled by Stephen Warren, Ph.D., W. T. Timmie Professor of Biochemistry in the Emory University School of Medicine, and a Howard Hughes Medical Institute Investigator (see sidebar), will try to further clarify the molecular basis of fragile X syndrome and expand the scope of contemporary fragile X syndrome research.

In recent years there has been a spectacular increase in the understanding of the fragile X syndrome, with many of the major discoveries originating in Dr. Warren's laboratory. Dr. Warren and his colleagues discovered in 1991 the gene responsible for fragile X syndrome, FMR1, and were among the first to develop genetic tests to diagnose the disease. In 1993 they discovered FMRP, the protein expressed by the normal FMR1 gene and learned that fragile X syndrome occurs when the FMR1 gene does not produce the FMRP protein. That protein suppression is responsible for the symptoms of the disease, namely mental retardation, attention deficit disorder and connective tissue disorders.

The scientists also learned that most affected patients share a common genetic mutation called triplet repeats. All genes are made of combinations of four chemicals, abbreviated A, C, G and T. Within the FMR1 gene, the triple combination of CGG, CGG, etc., is usually repeated only 30 times in unaffected persons, but between 230 to 1,000 times in those affected by fragile X syndrome.

With this knowledge, genetic counselors have been able to help carriers of FMR1 predict the probability of giving birth to a child affected by the syndrome, and pediatricians and medical geneticists have been able to provide perinatal testing of babies to determine if they might be affected by fragile X syndrome. Moreover, these data helped explain the "Sherman paradox", named after Dr. Stephanie Sherman, associate professor of genetics and a co-investigator on the program project. Dr. Sherman first noted nearly a decade ago that fragile X syndrome did not get passed on to offspring with the usual probabilities common among most genetic disorders. This variance from the norm was unexplained for a number of years, hence the "paradox," until the gene was discovered and the influence of the expanded CGG repeat was found to be responsible for the effect.

Despite these significant breakthroughs, key questions about fragile X remain unanswered. The new grant will use novel genetic, molecular biological, neurobiological and biochemical approaches to the syndrome, including cell culture, transgenic mice and yeast systems to help uncover additional answers.

The seven projects will be led by a diverse group of both established and newer Emory investigators, including Drs. Warren and Sherman; Ye Feng, Ph.D., assistant professor of biochemistry; Judy Fridovich-Keil, Ph.D., assistant professor of genetics; Steven Hersch, M.D., Ph.D., assistant professor of neurology; Daniel Reines, Ph.D., associate professor of biochemistry; and Keith Wilkinson, Ph.D., professor of biochemistry. Six out of the seven already have published one or more research papers on fragile X syndrome, representing a total of 65 published manuscripts from Emory on the disorder.

"It is unlikely that there are many other institutions with a similar group of investigators with such a history or track record of fragile X syndrome research," notes Dr. Warren. "And since our investigators represent several scientific disciplines, this program will significantly expand the scope and breadth of contemporary fragile X research."

The team will seek clues to the mechanisms of the triple-repeat expansion and the suppression of FMRP during transcription as well as the role of FMRP on protein translation and the consequence of its absence on protein synthesis in neurons in specific regions of the brain and spine. They will develop model systems, including one to investigate yeast genes that express proteins similar to FMRP, and a new generation of FMR1 knockout mice in which they can closely control FMRP expression, both pre- and postnatally, through drug exposure. The investigators also will address fundamental questions relating to possible future therapeutic strategies.

Stephen T. Warren, Ph.D., is the only Howard Hughes Medical Institute (HHMI) Investigator in the State of Georgia. The HHMI, located in Chevy Chase, MD, was founded in 1953 by the aviator-industrialist, Howard R. Hughes. It is a scientific and philanthropic organization whose primary purpose is conducting biomedical research.

Currently there are more than 330 Howard Hughes Medical Institute investigators. Widely recognized for their creativity and productivity, they include several Nobel Prize winners and more than 50 members of the National Academy of Sciences. The scientists are employed by HHMI and conduct their work at HHMI facilities at leading research institutions nationwide under collaborative relationships with those institutions.

Through its Grants Program, HHMI supports the research of outstanding biomedical scientists in selected countries outside the United States. These International Research Scholars are located in nations as diverse as Mexico, Australia and the former Soviet Republics. In conjunction with the National Institutes of Health (NIH), the Institute maintains the Research Scholars Program, which provides research opportunities for selected medical students in the laboratories of NIH scientists.
-end-


Emory University Health Sciences Center

Related Protein Articles from Brightsurf:

The protein dress of a neuron
New method marks proteins and reveals the receptors in which neurons are dressed

Memory protein
When UC Santa Barbara materials scientist Omar Saleh and graduate student Ian Morgan sought to understand the mechanical behaviors of disordered proteins in the lab, they expected that after being stretched, one particular model protein would snap back instantaneously, like a rubber band.

Diets high in protein, particularly plant protein, linked to lower risk of death
Diets high in protein, particularly plant protein, are associated with a lower risk of death from any cause, finds an analysis of the latest evidence published by The BMJ today.

A new understanding of protein movement
A team of UD engineers has uncovered the role of surface diffusion in protein transport, which could aid biopharmaceutical processing.

A new biotinylation enzyme for analyzing protein-protein interactions
Proteins play roles by interacting with various other proteins. Therefore, interaction analysis is an indispensable technique for studying the function of proteins.

Substituting the next-best protein
Children born with Duchenne muscular dystrophy have a mutation in the X-chromosome gene that would normally code for dystrophin, a protein that provides structural integrity to skeletal muscles.

A direct protein-to-protein binding couples cell survival to cell proliferation
The regulators of apoptosis watch over cell replication and the decision to enter the cell cycle.

A protein that controls inflammation
A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Resurrecting ancient protein partners reveals origin of protein regulation
After reconstructing the ancient forms of two cellular proteins, scientists discovered the earliest known instance of a complex form of protein regulation.

Sensing protein wellbeing
The folding state of the proteins in live cells often reflect the cell's general health.

Read More: Protein News and Protein Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.